Migraine Archives - Neurology Advisor


liver function test

Investigational Ubrogepant Does Not Confer Hepatotoxicity in Healthy Individuals

Ubrogepant — a small-molecule, orally delivered, and specific calcitonin gene-related peptide receptor antagonist under investigation for acute treatment of migraine — features a favorable tolerability profile in healthy adults, study results published in Cephalalgia suggest. Calcitonin gene-related peptide receptor antagonism was previously shown to be effective in the acute treatment of migraine attacks. However, the…

Next post in AAN 2019 Conference